Commons Capital’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Hold
38,000
0.32% 54
2025
Q4
$406K Hold
38,000
0.27% 66
2025
Q3
$519K Hold
38,000
0.34% 58
2025
Q2
$534K Hold
38,000
0.4% 52
2025
Q1
$512K Hold
38,000
0.47% 49
2024
Q4
$670K Buy
38,000
+10,563
+38% +$196K 0.61% 39
2024
Q3
$525K Hold
27,437
0.58% 33
2024
Q2
$599K Buy
+27,437
New +$731K 0.72% 30
2023
Q4
Sell
-4,200
Closed -$314K 60
2023
Q3
$314K Buy
+4,200
New +$373K 0.54% 38

Other funds holding MED

Commons Capital's MED Position: Q1 2026 in Review

Commons Capital held its Medifast (MED) position steady in Q1 2026 at 38,000 shares worth $387K. The position accounts for 0.32% of the portfolio, ranked #54.

Commons Capital first reported a position in MED in Q3 2023 and has held it in 9 quarters since. The position peaked at $670K in Q4 2024. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Commons Capital held 38,000 shares of Medifast worth $387K as of Q1 2026.
  • Commons Capital left its Medifast share count unchanged in Q1 2026.
  • Medifast made up 0.32% of Commons Capital's portfolio in Q1 2026, its #54 holding.
  • Commons Capital first reported a position in Medifast in Q3 2023 and has held it in 9 quarters since.
  • Commons Capital's Medifast position peaked at $670K in Q4 2024.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Commons Capital's 13F filing for Q1 2026, filed 30 Apr 2026.